Chemistry: molecular biology and microbiology – Treatment of micro-organisms or enzymes with electrical or... – Modification of viruses
Patent
1990-09-27
1991-12-24
Martinell, James
Chemistry: molecular biology and microbiology
Treatment of micro-organisms or enzymes with electrical or...
Modification of viruses
435 6, 435 71, 435 737, 435 693, 43525233, 4353201, C12N 1500, C12N 1572
Patent
active
050752286
ABSTRACT:
Disclosed is a clone and the process for cloning genes encoding the genus-specific lipopolysaccharide antigen of chlamydia. The clone is a hybrid lipopolysaccharide molecule composed of both chlamydia and E. coli components.
REFERENCES:
Wenman et al., "Expression in E. coli of Chlamydia trachomatis Antigen Recognized During Human Infection", Nature 296: 68 (1982).
Allan et al., "Molecular Cloning of the Major Outer Membrane Protein of Chlamydia trachomatis", Infec. Immun. 45: 637 (1984).
Curtiss, "Antigenic Products of Recombinant Genes and Related Vaccines", Chem; Abstr. 99: 146100y (1983) of Eur. Pat. Appl. EP 80, 806 (Jun. 8, 1983).
Caldwell Harlan D.
Nano Francis E.
Martinell James
United States of America
LandOfFree
Recombinant clones of Chlamydia trachomatis lipopolysaccharide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant clones of Chlamydia trachomatis lipopolysaccharide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant clones of Chlamydia trachomatis lipopolysaccharide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-43007